NO20072155L - Clostridium-nevrotoksiner for anvendelse i vevheling - Google Patents
Clostridium-nevrotoksiner for anvendelse i vevhelingInfo
- Publication number
- NO20072155L NO20072155L NO20072155A NO20072155A NO20072155L NO 20072155 L NO20072155 L NO 20072155L NO 20072155 A NO20072155 A NO 20072155A NO 20072155 A NO20072155 A NO 20072155A NO 20072155 L NO20072155 L NO 20072155L
- Authority
- NO
- Norway
- Prior art keywords
- neurotoxins
- tissue
- clostridium
- local administration
- clostridium neurotoxins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61339204P | 2004-09-27 | 2004-09-27 | |
| PCT/GB2005/003728 WO2006035225A1 (fr) | 2004-09-27 | 2005-09-27 | Neurotoxines clostridiennes favorisant la cicatrisation de tissus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072155L true NO20072155L (no) | 2007-04-26 |
Family
ID=35355850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072155A NO20072155L (no) | 2004-09-27 | 2007-04-26 | Clostridium-nevrotoksiner for anvendelse i vevheling |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060067950A1 (fr) |
| EP (1) | EP1799254A1 (fr) |
| KR (1) | KR20070057862A (fr) |
| CN (1) | CN101027083A (fr) |
| AU (1) | AU2005288758A1 (fr) |
| BR (1) | BRPI0516134A (fr) |
| CA (1) | CA2580122A1 (fr) |
| EA (1) | EA200700739A1 (fr) |
| IL (1) | IL182153A0 (fr) |
| MX (1) | MX2007003407A (fr) |
| NO (1) | NO20072155L (fr) |
| WO (1) | WO2006035225A1 (fr) |
| ZA (1) | ZA200702484B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
| AR061669A1 (es) * | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
| US10792344B2 (en) | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
| EP2236520A1 (fr) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Composition de stabilisation pour biomolécules immobilisées |
| WO2015126527A1 (fr) * | 2014-02-18 | 2015-08-27 | Kaufman-Janette Joely | Neurotoxine botulique pour une utilisation dans le traitement prophylactique de plaies cutanées |
| US20200023044A1 (en) * | 2017-03-22 | 2020-01-23 | Bonti, Inc. | Botulinum neurotoxins for treating traumatic injuries |
| WO2018175688A1 (fr) * | 2017-03-22 | 2018-09-27 | Bonti, Inc. | Neurotoxines botuliques pour utilisation en thérapie |
| CN107469065B (zh) * | 2017-07-19 | 2021-05-18 | 广州医科大学 | 类蛇毒三胜肽在制备用于治疗皮肤溃疡的药物中的应用 |
| US20190183987A1 (en) * | 2017-12-18 | 2019-06-20 | Bonti, Inc. | Neurotoxins for use in minimizing scarring |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69620888T2 (de) * | 1996-11-27 | 2002-08-14 | William J Binder | Neurotoxine zur Behandlung von Hauterkrankungen bei Säugetieren |
| MXPA01004254A (es) * | 1998-10-27 | 2002-04-24 | Mayo Foundation | Metodos para intensificar la curacion de heridas. |
| DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
| US8048423B2 (en) * | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
-
2005
- 2005-09-27 BR BRPI0516134-7A patent/BRPI0516134A/pt not_active IP Right Cessation
- 2005-09-27 WO PCT/GB2005/003728 patent/WO2006035225A1/fr active Application Filing
- 2005-09-27 AU AU2005288758A patent/AU2005288758A1/en not_active Abandoned
- 2005-09-27 KR KR1020077006802A patent/KR20070057862A/ko not_active Application Discontinuation
- 2005-09-27 CN CNA2005800326132A patent/CN101027083A/zh active Pending
- 2005-09-27 CA CA002580122A patent/CA2580122A1/fr not_active Abandoned
- 2005-09-27 US US11/235,775 patent/US20060067950A1/en not_active Abandoned
- 2005-09-27 MX MX2007003407A patent/MX2007003407A/es not_active Application Discontinuation
- 2005-09-27 EA EA200700739A patent/EA200700739A1/ru unknown
- 2005-09-27 EP EP05787027A patent/EP1799254A1/fr not_active Withdrawn
-
2007
- 2007-03-22 IL IL182153A patent/IL182153A0/en unknown
- 2007-03-26 ZA ZA200702484A patent/ZA200702484B/xx unknown
- 2007-04-26 NO NO20072155A patent/NO20072155L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101027083A (zh) | 2007-08-29 |
| ZA200702484B (en) | 2008-11-26 |
| BRPI0516134A (pt) | 2008-08-26 |
| WO2006035225A1 (fr) | 2006-04-06 |
| EA200700739A1 (ru) | 2007-10-26 |
| IL182153A0 (en) | 2007-07-24 |
| EP1799254A1 (fr) | 2007-06-27 |
| MX2007003407A (es) | 2007-05-23 |
| CA2580122A1 (fr) | 2006-04-06 |
| US20060067950A1 (en) | 2006-03-30 |
| AU2005288758A1 (en) | 2006-04-06 |
| KR20070057862A (ko) | 2007-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072155L (no) | Clostridium-nevrotoksiner for anvendelse i vevheling | |
| Rabello et al. | Update on hypertrophic scar treatment | |
| ECSP077328A (es) | Neurotoxinas clostridiales para uso en la cicatrización de tejidos | |
| Oguntibeju | Medicinal plants and their effects on diabetic wound healing | |
| BR112016003358A2 (pt) | método para aumentar a expressão de proteínas codificadas por rna | |
| Verma et al. | Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis | |
| Jablonka et al. | Botulinum toxin to minimize facial scarring | |
| WO2009142772A3 (fr) | Méthodes et traitement d’allergies et inflammations associées à des pathologies gastro-intestinales | |
| MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
| Hong et al. | Impending skin necrosis after dermal filler injection: A “golden time” for first‐aid intervention | |
| NZ710157A (en) | Use of guanethidine for treating hypertension by local vascular delivery | |
| WO2004000164A3 (fr) | Liberation de molecules bioactives mediee par la membrane amniotique | |
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| MY190257A (en) | Optimised subcutaneous therapeutic agents | |
| van der Walt et al. | Modified Charles procedure using negative pressure dressings for primary lymphedema: a functional assessment | |
| JP2020511548A5 (fr) | ||
| Cha et al. | Does fibrin sealant reduce seroma after immediate breast reconstruction utilizing a latissimus dorsi myocutaneous flap? | |
| BR112013018365A2 (pt) | "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica" | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| ATE444076T1 (de) | Verwendung von botulintoxin zur linderung von hodenschmerzen | |
| Ballestas et al. | Trends in recurrent respiratory papillomatosis treatment | |
| Chiu | Management of secondary lymphoedema | |
| BRPI0800085A2 (pt) | composição farmacêutica e curativo para tratamento de lesões de pele, bem como uso de sal de cério associado a uma matriz de colágeno | |
| DK1869185T3 (da) | Konjugat med P21-protein til kræftbehandling | |
| CY1116672T1 (el) | Χρηση αδαπαλενης και βενζοϋλυπεροξειδιου για την μακροχρονια αντιμετωπιση της κοινης ακμης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |